« Back
Home /
HCV-1 e2 Protein (554-569) (TFA)

HCV-1 e2 Protein (554-569) (TFA)

Item no.	HY-P4027A-1ea
Manufacturer	MedChem Express
Amount	1 ea
Category	Peptides & Proteins Recombinant Proteins
Type	Proteins Recombinant
Specific against	other
Formula	C74H111N19O21S3.xC2HF3O2
Citations	[1]Zhang ZX, et al. Antigenic structure of the hepatitis C virus envelope 2 protein. Clin Exp Immunol. 1994 Dec;98(3):382-7.
Smiles	O=C(N[C@@H](CCSC)C(N[C@@H](CC(N)=O)C(N[C@@H](CO)C(N[C@@H]([C@H](O)C)C(NCC(N[C@@H](CC1=CC=CC=C1)C(N[C@@H]([C@H](O)C)C(N[C@@H](CCCCN)C(N[C@@H](C(C)C)C(N[C@@H](CS)C(NCC(N[C@@H](C)C(N2[C@@H](CCC2)C(N3[C@@H](CCC3)C(N[C@@H](CS)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC4=CNC5=CC=CC=C45)N.OC(C(F)(F)F)=O.[x]
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Shipping condition	Room temperature
Available
Manufacturer - Type	Peptides
Manufacturer - Applications	COVID-19-anti-virus
Manufacturer - Targets	HCV
Shipping Temperature	Room temperature
Product Description	HCV-1 e2 Protein (554-569) TFA is one of the main antigenic regions of HCV envelope 2 (e2) protein. The HCV-1 e2 Protein (554-569) TFA contains a putative N-glycosylation site, which was previously thought to influence the immune recognition of e2[1].
Manufacturer - Research Area	Infection
Solubility	10 mM in DMSO
Manufacturer - Pathway	Anti-infection
Clinical information	No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 ea

available

Request delivery time